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MicroRNA 139-5p coordinates APLNR-CXCR4
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G protein-coupled receptor (GPCR) signalling, including that involving apelin (APLN) and its
receptor APLNR, is known to be important in vascular development. How this ligand–receptor
pair regulates the downstream signalling cascades in this context remains poorly understood.
Here, we show that mice with Apln, Aplnr or endothelial-speciﬁc Aplnr deletion develop
profound retinal vascular defects, which are at least in part due to dysregulated increase in
endothelial CXCR4 expression. Endothelial CXCR4 is negatively regulated by miR-139-5p,
whose transcription is in turn induced by laminar ﬂow and APLN/APLNR signalling. Inhibition
of miR-139-5p in vivo partially phenocopies the retinal vascular defects of APLN/APLNR
deﬁciency. Pharmacological inhibition of CXCR4 signalling or augmentation of the
miR-139-5p-CXCR4 axis can ameliorate the vascular phenotype of APLN/APLNR deﬁcient
state. Overall, we identify an important microRNA-mediated GPCR crosstalk, which plays a
key role in vascular development.
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A
functional vascular system is fundamental for normal
vertebrate development, as it is critical for delivery of
oxygen and nutrients, while removing waste to ensure
growth and differentiation of all tissues. The concept of tip and
stalk cells has emerged over the past decade in the context of
sprouting angiogenesis, and guides our understanding of the
transition from vascular sprouting to maturation and ultimately
quiescence1,2. In this context, endothelial cell (EC) subsets can
respond to molecular and biomechanical cues, and acquire
non-proliferative tip cell identities which can extend numerous
ﬁlopodia and guide vascular outgrowth, or become stalk cells that
are considered proliferative and capable of forming lumens3. Both
the vascular endothelial growth factor (VEGF) and the Notch
signalling pathways have been extensively described to regulate
the discrimination between these cell populations during mouse
and zebraﬁsh development3–8. Despite the important role and
extensive characterization of the VEGF–Notch signalling
paradigm, several additional tip and stalk cell-speciﬁc genes
have been identiﬁed, including APLNR (stalk cells) and
CXCR4 (tip cells), whose genetic deletions lead to profound
vascular defects9–13. Moreover, several G protein-coupled
receptor (GPCR)-ligand combinations, including stromal cell-
derived factor 1 (SDF-1)/CXCR4, S1P/S1PR1 and apelin (APLN)/
APLNR, have been shown to play critical roles in vascular
development9–12,14–16. Nevertheless, unresolved questions
remain, and our understanding of the mechanisms by which
these signalling processes are integrated remains incomplete.
Here we deﬁne a novel mechanism by which signalling
pathways involving two of these GPCRs, namely APLNR and
CXCR4, are intricately linked in the developing vasculature. We
identify robust ﬂow-induced endothelial expression of APLNR in
both in vitro and in vivo models, which in turn leads to marked
suppression of endothelial CXCR4 expression. This crosstalk was
found to involve a key shear responsive microRNA (miRNA),
miR-139-5p, which is positively regulated by APLN/APLNR
signalling and directly targets CXCR4 in ECs. Moreover, we
demonstrate novel pharmacological strategies to restore this
signalling axis that rescue the vascular phenotypes associated with
APLN/APLNR deﬁciency. Overall, these ﬁndings provide key
mechanistic insights that involve a critical miRNA-based cross-
talk between two GPCR signalling cascades, which regulate
important early steps in vascular maturation.
Results
APLN/APLNR downregulates CXCR4 in developing retinal
vessels. Our previous investigation of the APLN/APLNR signal-
ling pathway included a gene expression proﬁling analysis of
transcripts that are differentially regulated by APLN/APLNR
knockdown in ECs (ref. 11). Of the transcripts that were
increased, we found that CXCR4 was one of the most
signiﬁcantly upregulated transcripts in this context (data set
GSE46825, Gene Expression Omnibus database (GEO NCBI)).
We conﬁrmed that both the messenger RNA (mRNA) and
protein levels of CXCR4 are signiﬁcantly increased in human
umbilical vein ECs (HUVECs) subjected to APLN or APLNR
knockdown (Fig. 1a–d). Conversely, ﬂow cytometry analyses
demonstrated signiﬁcant decrease in CXCR4 expression in
response to APLNR overexpression in HUVECs (Fig. 1e). To
further validate this inverse correlation between APLNR and
CXCR4 in vivo, we examined mice with genetic deletion of either
Aplnr or Apln. Expression of Cxcr4 in postnatal day 5 (P5) retinas
of both the Aplnr / and Apln / mice, as detected by in situ
hybridization, was markedly increased compared with respective
littermate controls (Fig. 1f). Moreover, to quantitatively assess the
changes in endothelial Cxcr4 expression in vivo, we carried out
ﬂow cytometry analysis using retinas from Aplnr / mice and
found signiﬁcantly higher expression of Cxcr4 in the retinal ECs
compared with littermate controls (Supplementary Fig. 1). Both
the Apln / and Aplnr / mice also exhibited a signiﬁcant
delay in retinal vascular growth, decreased total vascularized area
and vascular branchpoints at P5, as previously demonstrated
(Supplementary Fig. 2a,b)12,17,18. To conﬁrm that these
phenotypes are speciﬁcally due to endothelial APLNR
signalling, we investigated the retinal vascular phenotype in
mice with conditional, endothelial-speciﬁc deletion of Aplnr
(Aplnrﬂ/ﬂ;Cdh5-CreERT2) using a tamoxifen inducible Cdh5 Cre
driver (Cdh5-CreERT2)19 (Supplementary Fig. 3a,b). We found
that mice lacking Aplnr selectively in the endothelium
recapitulated the Aplnr global knockout phenotype in the
retina, albeit less severely (Fig. 1g,h). These mice also exhibited
higher levels of Cxcr4 expression in retinal ECs as analysed by
ﬂow cytometry (Supplementary Fig. 3c).
Prior studies have shown that loss of CXCR4 signalling results
in spindle-like tip cells that fail to migrate properly10; however,
the effects of excess CXCR4 are not known. To investigate
whether the Apln / and Aplnr / vascular phenotypes are in
part a consequence of increased CXCR4 signalling, we injected
newborn mice with AMD3100, a known selective CXCR4
inhibitor20. First, we conﬁrmed that AMD3100 can inhibit
effects of SDF-1a in inducing endothelial sprouting in a ﬁbrin gel
bead assay (Supplementary Fig. 4). For our in vivo studies, as
previous studies have demonstrated vascular abnormalities with
high doses of AMD3100 (ref. 21), we chose a dose that was
subphenotypic in control mice (Supplementary Fig. 5) and
examined the retinal vasculature of the Aplnr / mice at P5. We
found a signiﬁcant increase in total vascularized area and vascular
branchpoints of the Aplnr / mice treated with AMD3100
compared with the PBS injected controls (Fig. 1i,j); the radial
growth of the retinas was not signiﬁcantly changed, suggesting a
partial rescue of the Aplnr / phenotype. Moreover, we also
achieved partial rescue of the Aplnrﬂ/ﬂ; Cdh5-CreERT2 mice with
AMD3100, with increase in total vascularized area and trends
towards increase in number of vascular branchpoints and radial
growth (Supplementary Fig. 6a,b).
Endothelial APLNR expression is ﬂow-dependent. We eval-
uated the retinal vasculature of P5 mice and conﬁrmed that the
expression of Aplnr was restricted to the stalk cells and maturing
veins (Fig. 2a), whereas Apln was predominantly expressed by tip
cell population (Fig. 2b), as previously reported12,22. We found
that the expression of Aplnr was highest in the subset of ECs that
surround the newly formed lumen, based on the perfusion
pattern observed in ﬂuorescein isothiocyanate (FITC) dextran
injected P5 mice (Fig. 2c)3. Given the restricted Aplnr expression
in the retinal vasculature to the leading edge of the lumenized
network, which would be the endothelial subset exposed to early
onset of blood ﬂow, we evaluated whether shear stress may be a
positive regulator of APLNR expression. The type of ﬂow in this
context has been modelled in silico23, but remains poorly
characterized in vivo. We tested the effects of a number of
different ﬂow conditions on APLNR expression in HUVECs
(Supplementary Fig. 7a). Of the different conditions of ﬂow
tested, we found the highest upregulation of APLNR with orbital
shear stress (estimated to induce 10.7 dynes cm 2)24. We also
conducted a serial time course to determine the effect of duration
of ﬂow on APLNR expression levels, and found that the highest
induction was observed at 48 h, while the expression levels began
to decrease beyond that time (Supplementary Fig. 7b). Moreover,
we found that upregulation of APLNR was at least in part
dependent on the shear responsive transcription factors KLF2
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and KLF4, as knockdown of KLF2, KLF4 or both, markedly
inhibited the shear-mediated APLNR upregulation (Fig. 2d). In
addition, ERK5 knockdown, a known shear responsive MAP
kinase upstream of KLF2 and KLF4 (ref. 25), also abrogated
induction of APLNR expression under shear conditions (Fig. 2e).
In contrast to APLNR, APLN expression was signiﬁcantly
downreguated after exposure of HUVECs to shear stress
(Supplementary Fig. 8). Lastly, we investigated the role of the
second APLNR ligand, namely Toddler (ELABELA)26,27 and
found no effect on CXCR4 expression levels by either its
endogenous knockdown or stimulation with exogenous peptide
in HUVECs (Supplementary Fig. 9a,b).
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Figure 1 | Apelin/APLNR regulates CXCR4 expression in vitro and in vivo. (a–d) CXCR4 transcript and protein levels in response to siRNA-mediated
knockdown of APLNR (a,b) or APLN (c,d). n¼ 3 experiments per condition. (e) Flow cytometry to determine level of CXCR4 expression in HUVECs
transfected with either APLNR-GFP or GFP expression constructs. Data shown represents the CXCR4 staining of cells among the GFP-positive cells.
n¼ 3 experiments. (f) Cxcr4 expression (blue) in P5 retinal vessels as assessed by in situ hybridization in Aplnr/ and Apln / mice. Arrows indicate
Cxcr4 mRNA localization. Isolectin B4 is shown in white. Scale bar, 100mm. n¼ 8 retinas per genotype. (g,h) Retinal vasculature of P5 mice with
endothelial-speciﬁc deletion of Aplnr (Aplnrﬂ/ﬂ;Cdh5-CreERT2). Graphs depict vascularized area, branchpoints and radial expansion. Scale bar, 200mm.
nZ6 retinas per genotype. (i,j) Effect of AMD3100 on Aplnr/ retinal vasculature. Scale bar, 200mm. nZ5 retinas per genotype. *Po0.05, **Pr0.01,
***Pr0.001, t-test. Error bars represent s.e.m.
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Figure 2 | APLNR is expressed in newly lumenized vessels and its expression is ﬂow-dependent. (a) Aplnr expression as determined by in situ
hybridization (blue) in P5 retinal vasculature with Isolectin B4 staining (white). The boxed area in the middle image is magniﬁed on the right to show higher
magniﬁcation of the adjacent panel. Scale bar, 50mm. n¼ 3 retinas. (b) Apln expression as determined by in situ hybridization (blue) in P5 retinal
vasculature with Isolectin B4 staining (white). The boxed area is magniﬁed on the right to show higher magniﬁcation of the adjacent panel. Scale bar,
100mm (low magniﬁcation) or 50mm (high magniﬁcation). n¼4 retinas. Tip cells are marked by the asterisks. (c) Localization of FITC Dextran in the P5
retinal vasculature (green) with Isolectin B4 (red) and Erg123 (endothelial nuclei) staining (blue). The higher magniﬁcation images are shown in the right
panels. Scale bar, 50mm. n¼4 retinas. (d) APLNR transcript expression in response to shear stress alone or with concurrent KLF2, KLF4 or combined
knockdown via siRNA. (e) APLNR transcript expression in response to shear stress alone or with concurrent ERK5 knockdown via siRNA. (f) Aplnrb
expression in the trunk and tail of zebraﬁsh embryos at 50 hpf with or without nifedipine (2 h treatment). Arrows (DMSO) and arrowheads (nifedipine)
demarcate aplnrb expression. (g) Aplnrb expression in the trunk and tail of zebraﬁsh embryos at 48 hpf with sih or control morpholino (MO) injection.
Asterisks mark absence of aplnrb staining in intersegmental vessels (ISVs). Staining in the posterior cardinal vein (PCV) is also reduced. In situ hybridization
with the pan-endothelial marker vascular endothelial cadherin (ve-cadherin) shows normal vascular morphology in all conditions. Arrows mark
intersegmental blood vessels. Scale bar, 50mm. **Pr0.01, ***Pr0.001, t-test. Error bars represent s.e.m.
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To further validate the shear-mediated APLNR regulation
in vivo, we utilized the zebraﬁsh embryonic system to evaluate the
expression of the two paralogous apln receptors, namely aplnra
and aplnrb, under disrupted ﬂow conditions. At baseline, aplnrb
expression was localized to the intersegmental vessels (ISVs) of
48–50 h post fertilization (hpf) embryos, as determined by in situ
hybridization (Fig. 2f,g). Following treatment of the embryos with
nifedipine, which is known to impede blood ﬂow28, or by
injection of the silent heart (sih) morpholino29, there was a
signiﬁcant decrease in aplnrb expression in the ISVs;
demonstrating in vivo that blood ﬂow is a critical regulator of
aplnrb expression (Fig. 2f,g). The ISV vascular structure was
unaffected, as conﬁrmed by ve-cadherin staining. Aplnra
expression in the ISVs, which was at baseline markedly lower
than aplnrb, was either slightly increased or unchanged by
nifedipine treatment or sih morpholino injection, respectively
(Supplementary Fig. 10a,b).
APLN/APLNR regulation of CXCR4 is miR-139-5p dependent.
Previous studies have demonstrated that shear stress can inhibit
endothelial CXCR4 expression30. We found that the shear-
induced downregulation of CXCR4 was abrogated by concurrent
knockdown of APLNR (Fig. 3a,b), suggesting that APLNR
signalling is a critical mediator of ﬂow-induced CXCR4
inhibition. Given the inverse relation between endothelial
expression of APLNR and CXCR4, we sought to determine the
mechanism by which APLNR regulates CXCR4 expression.
Multiple mechanisms are known to affect CXCR4 expression,
including emerging data suggesting an important role for
miRNA-mediated regulation in different contexts such as
breast31, prostate32, colon33 and thyroid34 cancer. The role of
miRNAs as potential regulators of CXCR4 expression in ECs has
not been thus far investigated. We ﬁrst determined whether
miRNAs in general may be playing a role in regulation of CXCR4
in ECs. We subjected HUVECs to Argonaute 2 (AGO2)
knockdown, a key protein of the RNA-induced silencing
complex, and found a signiﬁcant increase in CXCR4 expression,
suggesting that basal expression of CXCR4 may be miRNA
regulated (Fig. 3c). We additionally found that shear-induced
downregulation of CXCR4 was also abrogated by concurrent
knockdown of AGO2 (Fig. 3d), demonstrating that a miRNA-
based mechanism may be critical in the regulation of CXCR4
expression in the maturing vasculature.
We next set out to identify the miRNA that may be
instrumental in APLN/APLNR-mediated CXCR4 regulation.
We previously conducted a miRNA expression proﬁling array
using ECs subjected to APLN and/or APLNR knockdown,
with identiﬁcation of multiple miRNAs that are differentially
regulated in this context35. Of the miRNAs that were identiﬁed
in this setting, one in particular, namely miR-139-5p,
is predicted to bind the 30 untranslated region (UTR) of
CXCR4 at two independent loci (Supplementary Fig. 11a,b),
and was signiﬁcantly downregulated by disruption of endothelial
APLN/APLNR signalling35. To further investigate these
relationships in vivo, we evaluated the expression levels of
miR-139-5p in isolated retinal ECs from the eyes of P5 Apln /
and Aplnr / mice. We found signiﬁcantly decreased
miR-139-5p levels in ﬂuorescence-activated cell-sorted retinal
ECs from Apln / and Aplnr / mice compared with wild-
type littermates (Fig. 3e). To further elucidate the association
between miR-139-5p and APLN/APLNR signalling, we evaluated
the recently described Aplnr-CreERT; mTmG mice36, which
express green ﬂuorescent protein (GFP) driven by the Aplnr
promoter. Expression of miR-139-5p in vivo was signiﬁcantly
enriched in GFPþ retinal cells at P5, further demonstrating the
association between APLN/APLNR signalling and miR-139-5p
expression (Supplementary Fig. 12). In addition, we found that
APLNR knockdown decreases the transcripts of both PDE2A, the
host gene for miR-139-5p, as well as pri-miR-139, the primary
transcript of miR-139-5p (Supplementary Fig. 13), suggesting
a direct transcriptional relationship between APLNR and
miR-139-5p. We next tested the efﬁcacy of miR-139-5p in
regulating endothelial CXCR4 expression. Overexpression of
miR-139-5p in HUVECs resulted in signiﬁcant decrease in the
protein levels of CXCR4 (Fig. 3f). Conversely, we found that
inhibition of miR-139-5p via an anti-miR inhibitor resulted in
increased CXCR4 protein levels (Fig. 3f). Moreover, a luciferase
reporter activity containing the wild-type CXCR4 30 UTR
was signiﬁcantly decreased by mir-139-5p overexpression in
HUVECs, whereas the same construct with mutagenized
miR-139-5p binding sites was unaffected (Supplementary
Fig. 14).
Endothelial CXCR4 is closely regulated by miR-139-5p. To
further elucidate the relevance of our ﬁndings to the developing
vascular context, we examined whether there is a relationship
between shear stress and miR-139-5p. We found that miR-139-5p
was signiﬁcantly induced by exposure of ECs to shear stress
(Fig. 3g). Moreover, upregulation of miR-139-5p in response to
shear exposure was abrogated by concurrent knockdown of
APLNR, demonstrating the key role of APLNR in mediating shear
response in ECs (Fig. 3g). In addition, shear-stress-mediated
decrease in CXCR4 expression was abrogated by concurrent
inhibition of miR-139-5p (Fig. 3h).
We carried out additional functional studies to investigate the
role of miR-139-5p in ECs. Sprouting of ECs in response to
SDF-1a was signiﬁcantly reduced in ECs overexpressing
miR-139-5p, whereas sprouting in response to VEGF 165 was
unaffected (Fig. 3i). Similarly, HUVECs transfected with an
anti-miR against miR-139-5p sprouted more efﬁciently in
response to SDF-1a compared with control transfected cells,
while VEGF-induced sprouting was not affected by anti-miR
transfection (Supplementary Fig. 15a). Moreover, cell migration
in response to SDF-1a was also signiﬁcantly impeded in HUVECs
overexpressing miR-139-5p (Fig. 3j), whereas HUVECs
transfected with anti-miR-139-5p had enhanced migration to
SDF-1a stimulation (Supplementary Fig. 15b). The migratory
response to VEGF 165 was not affected by anti-miR-139-5p
(Supplementary Fig. 15b).
Next, we further validated our ﬁndings in vivo, using the
recently described 7C1 nanoparticles that are capable of selec-
tively targeting oligonucleotide delivery to the endothelium37.
Intravenous injection of anti-miR-139-5p loaded 7C1
nanoparticles led to partial phenocopying of the Apln / and
Aplnr / phenotype, with signiﬁcantly reduced vascularized
area and radial expansion and trend towards reduced number of
branchpoints, compared with mice injected with 7C1 loaded with
non-targeting control (cel-miR-67-3p; Fig. 4a,b).
Restoring miR-139-5p-CXCR4 axis rescues Apln / phenotype.
To further validate the role of miR-139-5p as a key downstream
element of APLN/APLNR signalling in vascular maturation, we
sought to identify a pharmacological strategy to restore its
endothelial expression. We screened multiple Food and Drug
Administration (FDA) approved compounds to determine
whether any of them can induce miR-139-5p expression. Of the
six compounds examined, we found that atorvastatin, belonging
to the class of 3-hydroxy-3-methyl-glutaryl-CoA reductase
inhibitors38, induced the highest increase in miR-139-5p
expression in HUVECs (Fig. 4c). We further investigated
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via anti-miR. (i) Sprouting assay using HUVEC covered beads transduced with miR-139-5p or control lentivirus in response to SDF-1a or VEGF 165. Scale
bar, 175mm. (j) Migration assay of HUVECs transduced with miR-139-5p or control lentivirus in response to SDF-1a. Scale bar, 200mm. *Po0.05,
**Pr0.01, ***Pr0.001, ###Pr0.001 against NC v/PBS, wwwPr0.001 against NC v/SDF-1a, t-test. Error bars represent s.e.m. n¼ 3 experiments per
condition.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms11268
6 NATURE COMMUNICATIONS | 7:11268 | DOI: 10.1038/ncomms11268 | www.nature.com/naturecommunications
whether atorvastatin can regulate CXCR4 expression; we found
that treatment of HUVECs with atorvastatin led to marked
inhibition of CXCR4 expression (Fig. 4d).
Our previous studies demonstrated that statins can augment
APLN/APLNR signalling, in an APLNR-dependent manner39.
Given the present data, we sought to investigate whether
atorvastatin can potentially rescue the retinal vascular
phenotype of mice with Apln or Aplnr deﬁciency. We found
that atorvastatin treatment of Apln / mice led to robust
improvement in retinal vascularized area, radial expansion and
increased the number of branchpoints (Fig. 4e,f). The phenotypic
rescue of either the Aplnr / or the Aplnrﬂ/ﬂ;Cdh5-CreERT2
mice were more modest (Supplementary Fig. 16a,b), likely in part
due to the more severe phenotype of these mice, and supporting
our previous data that endothelial signalling cascades induced by
statin are at least in part APLNR dependent39.
Discussion
Vascular development and maturation is a complex process
involving crosstalk among multiple independent, yet closely
integrated signalling cascades. VEGF and Notch signalling
pathways have been extensively characterized in this context as
key factors that provide an intricate orchestration of endothelial
identities and promote vascular network formation2. A distinct
set of signalling pathways whose characterization remains at a
relative infancy in this context is that mediated by GPCRs. The
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Figure 4 | Atorvastatin augments apelin/APLNR signalling and improves the Apln / retinal phenotype. (a,b) In vivo inhibition of miR-139-5p
postnatally with 7C1 nanoparticles loaded with anti-miR to miR-139-5p results in reduced vascularized area and radial expansion of retinal vasculature at
P5. n¼6 retinas per genotype. (c) Drug screen using clinically approved compounds that affect miR-139-5p expression levels in HUVECs. n¼ 3
experiments. (d) CXCR4 mRNA expression in HUVECs in response to atorvastatin stimulation. n¼ 3 experiments. (e,f) P5 retinal phenotype of Apln /
pups in response to treatment with atorvastatin. Vascularized area, vascular branchpoints and radial expansion are shown. Scale bar, 200mm. nZ4 retinas
per genotype. (g) Schematic representation of the proposed signalling cascade between APLNR, CXCR4 and the respective ligands in the developing
vasculature. *Po0.05, **Pr0.01, ***Pr0.001, t-test. Error bars represent s.e.m.
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importance of GPCR signalling in vascular development is
highlighted by the embryonic lethal phenotypes of several GPCRs
and their respective ligand knockout mice, described to display a
spectrum of cardiovascular defects9,11,14,40–43. However, their
downstream targets and interacting partners remain incompletely
deﬁned. Adding to the complexity are emerging studies that
demonstrate GPCR activation by mechanical forces such as
cellular stretch and shear stress in a ligand-independent manner,
which may in part explain the phenotypic differences between
ligand and receptor knockout mice44–46.
CXCR4 is a GPCR with widespread functional roles in a
number of contexts, including angiogenesis, hematopoiesis,
neurogenesis and immune function47. In the context of vascular
development, it has been established as a tip cell-speciﬁc gene
in the developing mouse and zebraﬁsh vasculature10,48.
Interestingly, it is one of a few tip cell enriched endothelial
genes that is also known to be markedly downregulated by shear
stress in vitro30, and by blood ﬂow in the zebraﬁsh in vivo48,49.
These ﬁndings suggest that CXCR4 needs to be strictly regulated
in the developing vasculature, to restrict the cellular response to
its ligands such as SDF-1a, and avoid the potential detriment of
inappropriate EC behaviour resulting from aberrantly expressed
CXCR4. Although this possibility has not been speciﬁcally
examined in the vascular context, whole embryo overexpression
of Cxcr4a in zebraﬁsh results in signiﬁcant craniofacial and
cartilage defects, highlighting the requirement for stringent
CXCR4 regulation50. In addition, although multiple studies
have suggested pro-angiogenic effects of augmenting CXCR4
signalling49,51,52, its restricted expression pattern in the
developmental context10,48 suggests the importance of limiting
expression to endothelial subsets for normal angiogenesis.
Mechanisms that regulate its expression, however, remain
inadequately deﬁned. The current body of work provides key
insights into a novel mechanism that integrates ﬂow, a secondary
GPCR signalling mediated by APLN/APLNR, and miR-139-5p, to
restrict endothelial CXCR4 expression in the context of vascular
development and maturation (Fig. 4g for schematic).
The abnormal vascular patterning of Apln and Aplnr null mice
likely involves a multitude of downstream signalling targets, some
of which have been described previously in other endothelial
contexts11. Our ﬁndings that CXCR4 expression is decreased by
APLNR-mediated signalling, and that inhibition of CXCR4 activity
with AMD3100 can achieve a partial rescue of the Aplnr / and
Aplnrﬂ/ﬂ;Cdh5-CreERT2 phenotype highlights the importance of
this mechanism, but also implicate other downstream targets that
are also likely involved in regulating processes such as cellular
proliferation and migration, lumen formation and maintenance,
and regulation of vascular permeability53. Ongoing studies will
further delineate the role of this and other related GPCR signalling
cascades in vascular maturation.
Onset of blood ﬂow, and subjecting ECs to shear stress leads to a
remarkable alteration in the endothelial behaviour and function.
Multiple in vivo models have demonstrated the role of ﬂow in
vascular development in murine54,55, avian56 and ﬁsh models57. A
number of shear responsive endothelial elements have also been
identiﬁed, including kinases (ERK5 (ref. 58), ERK1/2
(ref. 59) and AKT (ref. 60)), transcription factors (KLF2
(ref. 61), and KLF4 (ref. 62)) and other epigenetic modiﬁers
(miR-126 (ref. 57)). Our current ﬁndings highlight the induction of
APLNR expression in ECs subjected to shear stress, an effect that
was dependent at least in part on ERK5, KLF2 and KLF4, which are
genes with key ﬂow responsive roles in the endothelium.
The speciﬁc characterization of the ﬂow pattern in the developing
vascular bed remains incompletely deﬁned, although recent studies
have used computational analyses to estimate the shear proﬁles23.
We found induction of APLNR in ECs in response to multiple types
of shear stress, and furthermore showed that aplnrb, one of the two
paralogous apln receptors in the zebraﬁsh, was markedly decreased
with cessation of blood ﬂow.
miRNAs are emerging as vital rheostats in multiple biological
processes, and their key roles in the context of vascular
development are only beginning to be appreciated. The intricacies
of miRNA-mediated signalling integration in vascular
development remain at infancy, although recent studies have
demonstrated their key roles in angiogenesis57. Although
miR-139-5p has been described in a limited number of studies
as a potential tumour suppressor miRNA63,64, little is known
about the function or regulation of miR-139-5p in the
endothelium. Our current ﬁndings demonstrate two key aspects
of this highly regulated endothelial miRNA that is likely a critical
mediator of vascular maturation. First, we identiﬁed miR-139-5p
as a novel shear responsive endothelial miRNA, that is
APLN/APLNR dependent. Second, we found that miR-139-5p
is a key intermediary that links APLN/APLNR signalling with
repression of endothelial CXCR4 expression, which appears to be
essential for proper vascular maturation. Lastly, we show that
in vivo inhibition of miR-139-5p postnatally results in partial
phenocopying of the Apln / and Aplnr / phenotypes. We
expect that our ongoing studies into the role of miR-139-5p in the
endothelium, both in the developmental and the vascular disease
context, will shed greater insights into its functions.
A key aspect of our current ﬁndings is the effect of statins in
induction of miR-139-5p expression, inhibition of CXCR4
expression and pharmacological rescue of the retinal phenotype
of the Apln / mice. These ﬁndings provide support for our
previous ﬁndings describing the augmentation of APLNR-
mediated signalling by statins39, the mechanism of which will
require further investigation. From the perspective of statin
pleiotropy, these ﬁndings also invoke new potential endothelial
targets of statins, which may be playing a key role in mediating
the vascular protective effects of these agents in atherosclerosis.
In summary, the crosstalk between APLNR and CXCR4-
mediated pathways provide a novel mechanism that may be a
crucial determinant of vascular maturation. Further studies to
expand on these ﬁndings, as well as identiﬁcation of potential
relation between these elements and the role of VEGF–Notch
signalling cascade, will advance our understanding of the
signalling crosstalk involved in vascular maturation.
Methods
Animals. All animal experiments were conducted in compliance with the relevant
laws and institutional guidelines and were approved by Yale University Institu-
tional Animal Care and Use Committee and local animal ethics committees of the
Landesamt fu¨r Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen.
Aplnr / , Aplnrﬂ/ﬂ, Apln / , Cdh5-CreERT2 and Aplnr-CreER; RosamTmG
mice have been previously described19,36,65. All animals were maintained on a
C57Bl/6 background, except for Aplnr-CreER; RosamTmG which were on a mixed
background. Given the young age of the mice at the time of our studies, their
gender was not determined. To inhibit CXCR4, 5mg kg 1 of AMD3100
(Sigma-Aldrich) dissolved in PBS were injected intraperitoneally in mice at P0 and
P1. Injection with PBS was used as negative control. Atorvastatin (Cayman
Chemical) was dissolved in dimethyl sulfoxide (DMSO) at 15mgml 1 and further
diluted in PBS. Mice were injected intraperitoneally at P1, P2 and P3 with
40mg kg 1. Injection with PBS/DMSO was used as negative control. To induce
recombination of the Aplnr allele with the Cdh5-CreERT2 driver or recombination
of RosamTmG with the Aplnr-CreER driver, mice received intragastric injection of
100 mg of Tamoxifen (Sigma-Aldrich) dissolved in corn oil (Sigma-Aldrich) at P1
and P2. FITC Dextran (MW¼ 2 106Da; Sigma-Aldrich) was dissolved in water
and injected in the left ventricle of anaesthetized P5 pups and allowed to perfuse for
1min. 7C1 nanoparticles37 containing custom made miRIDIAN Hairpin inhibitors
for miR-139-5p or cel-miR-67-3p (Dharmacon) were injected daily intravenously
at 1mg kg 1 at P0–P2, via the superﬁcial temporal facial vein66. All mice for
retinal vasculature studies were killed at P5.
For zebraﬁsh blood ﬂow blocking experiments, a stock solution of 10mM
nifedipine (Sigma-Aldrich) in DMSO was diluted 1:4,000 (working concentration
2.5 mM) in E3 medium (diluted from a 60 stock containing 34.8 g NaCl, 1.6 g
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KCl, 5.8 g CaCl2 2H2O, 9.78 g MgCl 6H2O dissolved in 2 l H2O and pH
adjusted to 7.2 with NaOH) containing 2 tricaine and 0.003% phenylthiourea to
prevent pigmentation. Tricaine (2 ) was prepared by adding 8.4ml of a stock
solution (400mg tricaine powder, 97.9ml H2O, 2.1ml Tris (pH9), pH adjusted to
7.0) to 100ml of E3 medium. Embryos were incubated for 1 h and then ﬁxed in 4%
paraformaldehyde (PFA) for in situ hybridization experiments. For washout
experiments, embryos were washed once with E3 medium, and then transferred to
E3 medium without nifedipine.
Morpholinos targeting cardiac troponin T2 (silent heart (sih), 2 ng per embryo)
were designed to bind the translation start codon and ﬂanking 50 sequence
(50-CATGTTTGCTCTGATCTGACACGCA-30) and injected into embryos at
the 1 4 cell stage.
Immunostaining and in situ hybridization. Isolectin B4 staining (Life
Technologies, working concentration 20 mgml 1) was performed at room
temperature for 1 h or at 4 C overnight. Erg123 (ab92513, Abcam, 1/100) antibody
staining was performed at 4 C overnight. Alexa Fluor (Life Technologies, working
concentration 10mgml 1) secondary antibody was used. Retinal analysis of the
different mice was performed on at least four mice per genotype. Retinas were
analysed with a Nikon Eclipse 80i microscope, equipped with a Retiga 2000R
Fast1394 camera. NIS Elements software was used for image acquisition and Adobe
Photoshop CS5.1 and ImageJ and Matlab were used for image processing. For
quantiﬁcation of vascularized area, vascular branchpoints and radial expansion of
the retinas at least ﬁve images per retina were acquired at  20 magniﬁcation at the
tip-stalk cell border and between arteries and veins.
For in situ hybridization eyes from P5 pups were ﬁxed in 4% PFA for 30min at
4 C, before the retinas were collected and ﬁxed again in 4% PFA at 4 C overnight.
Retinas were dehydrated in methanol series and stored at  20 C until required.
Before hybridization, retinas were rehydrated to PBS/0.1% Tween and then
digested for 11min in 80 mgml 1 Proteinase K (Sigma-Aldrich) followed by
ﬁxation in 4% PFA/0.2% glutaraldehyde in PBS/0.1% Tween. Retinas were washed
in PBS/0.1% Tween, pre-incubated in hybridization buffer at 70 C for 3 h and then
incubated with RNA probes in hybridization buffer at 70 C overnight. Probes were
labelled with digoxigenin-uridine triphosphate (Roche) using full-length
complementary DNA (cDNA) clones and T7, T3 or Sp6 polymerases. The Apln
plasmid was a kind gift from A. Eichmann12, Aplnr and Cxcr4 plasmids were
purchased from Dharmacon (MMM1013-202766118, clone ID: 4457726,
MMM1013-202762695, clone ID: 3592479). After extensive washing the hybridized
probes were detected with alkaline phosphatase–conjugated anti-digoxigenin-
alkaline phosphatase antibody (11093274910, Roche, working concentration
0.375Uml 1) at 4 C overnight and signal was visualized with BM purple alkaline
phosphatase substrate (1144207001, Roche). Retinas were mounted using
Vectashield (Vector Labs) and imaged.
For zebraﬁsh in situ hybridization, aplnra and aplnrb probes were ampliﬁed
from cDNA of 19 somite stage-old embryos using the following primers: aplnra-
forward 50-GAAAGGCCCAAGTCACAGAG-30 and aplnra-reverse 50-GAGTTC
ACTATCTGATGTCAAACCA-30 , aplnrb-forward 50-GAAAGGCCCAAGTCAC
AGAG-30 and aplnrb-reverse 50-GAGTTCACTATCTGATGTCAAACCA-30 . The
T7 promotor was added to the 50 end of the reverse primer in a second round of
ampliﬁcation (T7-aplnra-reverse 50-GTAATACGACTCACTATAGGGAGTTCA
CTATCTGATGTCAAACCA-30 , T7-aplnrb-reverse 50-GTAATACGACTCACT
ATAGGGAGTTCACTATCTGATGTCAAACCA-30)67. The ve-cadherin probe
was synthesized using a plasmid containing a 1,395-bp cdh5 DNA segment. mRNA
was synthesized in vitro using digoxigenin-uridine triphosphate (Roche) and T7 or
T3 Polymerase (Roche).
Cells and reagents. HUVECs (Yale VBT Core) were cultured at 37 C in a 5%
CO2 incubator in EGM-2 medium (Lonza). For experimental treatments, HUVECs
(passages 3–7) were grown to 70-90% conﬂuence. Laminar or pulsatile shear stress
was applied to conﬂuent cell cultures at 12 or 12±5 dynes cm 2, respectively,
using a parallel plate chamber. A surface area of 14 cm2 on the HUVEC-seeded
slide was exposed to ﬂuid shear stress generated by perfusing culture medium over
the cells. The pH of the system was kept constant by gassing with 5% CO2/95% air
and the temperature was maintained at 37 C. Orbital shear stress, calculated at
10.7 dynes cm 2, was applied to conﬂuent cell cultures seeded in 6-well plates,
using an orbital shaker positioned inside an incubator. Orbital shear stress was
used for all shear experiments (other than alternate conditions for Supplementary
Fig. 7). Transient transfections of plasmids were performed with Fugene HD
(Promega) according to the manufacturer’s instructions. For gene silencing,
short interfering RNAs (siRNAs; Stealth siRNA, Invitrogen) were transfected
with RNAiMAX (Invitrogen) according to the manufacturer’s instructions.
Non-targeting control and anti-miR-139-5p oligonucleotides (Dharmacon)
were transfected with RNAiMAX (Invitrogen) according to the manufacturer’s
instructions. Control and miR-139 lentivirus constructs (System Biosciences) were
used to generate lentivirus particles with the Lenti-X HTX Packaging System
(Clontech) with Lenti-X Concentrator. For in vivo inhibition of miR-139-5p,
custom made miRIDIAN Hairpin inhibitors for miR-139-5p or cel-miR-67-3p
were used (Dharmacon) for packaging in the 7C1 nanoparticles37. To generate
7C1 nanoparticles, polyethyleneimine with a number molecular weight of 600
(PEI600, Sigma-Aldrich) was combined with 200 proof anhydrous ethanol
(Koptec) and an epoxide-terminated C15 lipid at a lipid:PEI molar ratio equal to
14:1. The mixture was heated at 90 C for 48 h before puriﬁcation was performed
with a silica column37. To formulate nanoparticles, puriﬁed 7C1 was combined
with 200 proof ethanol and (1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-
N-[methoxy(polyethylene glycol)-2000] (Avanti Polar Lipids) at a 7C1:lipid-
polyethylene glycol (PEG) molar ratio equal to 4:1 in a glass syringe. siRNA was
dissolved in pH 3 10mM citrate solution (Teknova) in a separate syringe. The two
syringes were connected to a syringe pump and the ﬂuid was pushed through a
microﬂuidic device. The resulting nanoparticles were dialyzed in 1 PBS and
ﬁltered through a 0.22-mm sieve before their size was characterized.
HUVECs were treated for 24 h with atorvastatin (working concentration 10 mM
in DMSO), vorinostat (working concentration 10 mM in PBS), resveratrol (working
concentration 10 mM in PBS), ezetimibe (working concentration 10 mM in PBS),
metformin (working concentration 100 mM in H2O) or rapamycin (working
concentration 20nM in EtOH; Cayman Chemical) with the corresponding controls.
Cell migration assay. HUVECs were incubated in 6-well plates in EGM-2
medium overnight. After serum starvation for 6 h with EBM-2 medium, the mono-
layer of HUVECs was scratched with a universal blue pipette tip and the widths of the
scratches in four ﬁelds per well were captured using a Zeiss microscope with a  10
objective. Cells were incubated for 9 h in starvation medium containing PBS and
50ngml 1 SDF-1a (SRP3252, Sigma-Aldrich). The same ﬁelds were captured again
after migration. Differences in the widths of scratches before and after migration were
calculated. The calculated width is an average of the widths of three measurements
taken from the same ﬁeld. The means and s.e.m. of triplicate wells were calculated. All
experiments were conducted at least three times.
Fibrin gel bead assay. HUVECs were mixed with Cytodex 3 microcarriers
(Amersham Pharmacia Biotech) at a concentration of 400 HUVECs per bead in
1ml EGM-2 medium. Beads with cells were shaken gently every 20min for 4 h at
37 C in 5% CO2. After incubation, the beads with cells were transferred to a
25 cm2 tissue culture ﬂask and left for 12–16 h in 5ml EGM-2. The following
day, these were washed three times with 1ml EGM-2 and resuspended at a
concentration of 200 cell-coated beads per ml in 2.5mgml 1 ﬁbrinogen
(Sigma-Aldrich) containing 0.15Uml 1 aprotinin (Sigma-Aldrich). A total of
500 ml ﬁbrinogen/bead solution was added to 0.625U of thrombin (Sigma-Aldrich)
in one well of a 24-well tissue culture plate. The ﬁbrinogen/bead solution was
allowed to clot for 5min at room temperature and then at 37 C in 5% CO2 for
15min. EGM-2 containing 50 ngml 1 SDF-1a (SRP3252, Sigma-Aldrich), or
20 ngml 1 VEGF 165 (293-VE, R&D Systems) was used. Fibroblasts were layered
on top of the clot at a concentration of 20,000 cells per well. The medium was
changed every other day, and SDF-1a and VEGF 165 were added daily.
30 UTR luciferase reporter assay. Human CXCR4 30 UTR reporter construct was
purchased from SwitchGear Genomics. For mutant analysis, the sequence 50-CTG
TAG-30 in the two predicted miR-139-5p binding sites was mutated to 50-GGA
TCC-30. HUVECs were transfected with the luciferase reporter constructs
containing the CXCR4 30 UTR variants, Renilla luciferase and 30 nM of either
miR-139-5p mimic or negative control miRNA. At 24 h after transfection, the cells
were lysed, and luciferase activity was measured using the Dual-Luciferase Reporter
Assay kit (Promega) according to the manufacturer’s instructions.
Flow cytometry. Up to four retinas of wild type or Aplnr / P5 mouse neonates
were pooled and incubated for 15min at 37 C in EBM-2 containing Collagenase A
(1.5mgml 1, 103578, Roche) and DNAase I (25mgml 1, 104159, Roche)
before cells were dissociated by gentle trituration. Cells were stained with FITC-
conjugated anti-CD31 antibody (558738, BD Biosciences, working concentration
5 mgml 1) or APC-conjugated anti-CXCR4 antibody (558644, BD Biosciences,
working concentration 2 mgml 1). Stained cells were sorted using a FACSAria
ﬂow cytometer (BD Biosciences) or an LSRII ﬂow cytometer (BD Biosciences).
When cells were collected, both the negative and positive selections were collected
in ice cold PBS and processed for RNA extraction and real-time (RT) PCR as
described below. Data quantiﬁcation was performed with FlowJo 7.6 software.
HUVECs transfected with GFP or APLNR-GFP (Origene) plasmids for 48 h
were detached from the culture dish, washed and subsequently resuspended with
PBS containing 5% FBS. The cells were incubated at 4 C for 30min with
phycoerythrin-conjugated CXCR4 antibody (551510, BD Biosciences, working
concentration 2 mgml 1). Cells were washed with PBS and CXCR4 expression was
analysed by ﬂow cytometry (BD FACScan). Data quantiﬁcation was performed
with FlowJo 7.6 software.
RNA analysis. Total RNA was extracted using the miRNeasy RNA isolation
kit (Qiagen). Puriﬁed RNA was reverse transcribed with the iScript cDNA
Synthesis Kit (Bio-Rad) or the TaqMan MicroRNA Reverse Transcription Kit
(Life Technologies). RT-PCR was performed with TaqMan probes for both genes
and miRNAs (Life Technologies). RT-PCR for miR-139-5p detected both the
human (hsa-miR-139-5p) and murine (mmu-miR-139-5p) variants. All miRNA
data were normalized to the internal control small RNAs RNU19 or U6. For the
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mRNA samples, ribosomal 18S was used as internal control. Individual RT-PCRs
were performed on a CFX96 (Bio-Rad) according to the manufacturer’s instruc-
tions. TaqMan probes were used for all genes.
Protein extraction and western blotting. HUVECs were lysed with RIPA lysis
buffer (Thermo Scientiﬁc) containing Halt Protease and Phosphatase Inhibitor
cocktail (Thermo Scientiﬁc). Total protein contents of soluble cell lysate were
measured using a Micro BCA Protein assay kit (Thermo Scientiﬁc). Western
blotting was performed using standard methods. Brieﬂy, total protein from each
sample was resolved by sodium dodecyl sulfate–polyacrylamide gel electrophoresis,
transferred to a polyvinylidene diﬂuoride membrane (Bio-Rad) and probed with
antibodies speciﬁc to CXCR4 (ab2074, Abcam, 1:2,000) and GAPDH (2118, Cell
Signaling, 1:3,000). Subsequently, the membranes were incubated with HRP-con-
jugated secondary antibodies (7074, Cell Signaling, 1:3,000) and developed using an
enhanced chemiluminescence detection method (Thermo Scientiﬁc). Uncropped
scans of key western blots are provided as a Supplementary Fig. 17.
Statistical analyses. Unless otherwise noted, all cell treatments, cell migration
and sprouting assays, western blots, quantitative PCR assays and in situ
hybridizations are representative of at least three independent experiments. Results
are reported as mean±s.e.m. Unpaired Student’s t-test was used to determine
statistical signiﬁcance. Post hoc analysis was performed using the Holm–Sidak
method. Po0.05 was considered signiﬁcant.
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